Baraclude: Clinical Trials

11 trials of Baraclude, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 2 terminated. 11 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 311Completed 9, Terminated 2

Follow Baraclude: new trials by email Literature Review of Baraclude trials Research Report on Baraclude

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors
Best Practice, Entecavir, Tenofovir Alafenamide - Hepatitis B Infection, Malignant Solid Neoplasm
Phase 3TerminatedSWOG Cancer Research Network42020-01-172024-05-20
Telbivudine Versus Entecavir in Reducing Serum HBsAg Levels in Patients With HBeAg-positive Chronic Hepatitis B
Telbivudine, Entecavir - Chronic Viral Hepatitis B Without Delta-agent
Phase 3CompletedAsan Medical Center982012-05-012017-01-26
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus Infection
Entecavir, Placebo - Chronic Hepatitis B Virus, Pediatric
Phase 3CompletedBristol-Myers Squibb1802010-06-302019-05-09
A Phase IIIb Study to Compare Entecavir Plus Tenofovir vs. Adefovir Added to Continuing Lamivudine Therapy in Adult Patients With Lamivudine-Resistant Hepatitis B Infection
Entecavir + Tenofovir, Adefovir + continuing Lamivudine - Chronic Hepatitis B
Phase 3TerminatedBristol-Myers Squibb42008-08-012010-11-23
Prevention of Hepatitis B Virus Reinfection After Liver Transplantation With Entecavir
Entecavir - Liver Transplantation, Hepatitis B
Phase 3CompletedHepNet Study House, German Liverfoundation202008-03-012014-11-05
Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant Virus
Entecavir, Tenofovir, Adefovir - Hepatitis B, Chronic
Phase 3CompletedBristol-Myers Squibb6292008-03-012013-11-21
Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in Naive Subjects With Chronic Hepatitis B
Entecavir, Entecavir + Tenofovir - Hepatitis B, Chronic
Phase 3CompletedBristol-Myers Squibb6692007-04-012013-03-15
Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection
entecavir - Hepatitis B, Chronic
Phase 3CompletedBristol-Myers Squibb1092007-04-012012-05-31
Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection
entecavir, adefovir - Hepatitis B, Chronic Disease
Phase 3CompletedBristol-Myers Squibb692004-12-012010-08-10
Continue Entecavir Rollover From China
Entecavir - Chronic Hepatitis B Virus
Phase 3CompletedBristol-Myers Squibb6002004-05-012010-02-02
Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients With Hepatic Decompensation
Entecavir (ETV), Adefovir (ADV) - Hepatitis B
Phase 3CompletedBristol-Myers Squibb1952003-08-012013-06-24

Conditions studied

Hepatitis B, Chronic (7)  ·  Hepatitis B (4)  ·  Chronic Disease (1)  ·  Liver Diseases (1)

Sponsors

Bristol-Myers Squibb (8)  ·  Asan Medical Center (1)  ·  HepNet Study House, German Liverfoundation (1)  ·  SWOG Cancer Research Network (1)

Countries

United States (8)  ·  Canada (5)  ·  Poland (5)  ·  Taiwan (5)  ·  Brazil (4)  ·  India (4)  ·  Italy (4)  ·  Russia (4)  ·  South Korea (4)  ·  Turkey (Türkiye) (4)  ·  Argentina (3)  ·  Australia (3)  ·  France (3)  ·  Germany (3)  ·  Greece (3)

Top investigators

Heiner Wedemeyer, MD (1)  ·  Jessica P Hwang (1)  ·  Michael P Manns, MD (1)  ·  Young-Suk Lim, M.D., Ph.D. (1)

Results publications

PMID 22643350, PMID 26223345, PMID 28103819

NIH funding

2008 (1), UG1CA189974 (1)